# POMx In the Treatment of Erectile Dysfunction

> **NCT01220206** · PHASE2 · COMPLETED · sponsor: **POM Wonderful LLC** · enrollment: 120 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** One POMx capsule daily
- **DRUG:** 2 POMx Capsules

## Key facts

- **NCT ID:** NCT01220206
- **Lead sponsor:** POM Wonderful LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220206, "POMx In the Treatment of Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01220206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*